NFSG
HZNP

Newbridge Financial Services Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Newbridge Financial Services Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40
Closed -$4.63K – 1364
2023
Q3 		$4.63K Hold
40
– – ﹤0.01% 966
2023
Q2 		$4.11K Hold
40
– – ﹤0.01% 1041
2023
Q1 		$4.37K Hold
40
– – ﹤0.01% 1094
2022
Q4 		$4.55K Hold
40
– – ﹤0.01% 1084
2022
Q3 		$2K Hold
40
– – ﹤0.01% 1260
2022
Q2 		$3K Hold
40
– – ﹤0.01% 1148
2022
Q1 		$4K Hold
40
– – ﹤0.01% 1172
2021
Q4 		$4K Hold
40
– – ﹤0.01% 1135
2021
Q3 		$4K Sell
40
-1
-2% -$104 ﹤0.01% 1087
2021
Q2 		$4K Hold
41
– – ﹤0.01% 1192
2021
Q1 		$4K Buy
+41
New +$3.46K ﹤0.01% 1099

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Newbridge Financial Services Group's HZNP Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 40 shares — an estimated $4.63K sold.

Newbridge Financial Services Group first reported a position in HZNP in Q1 2021 and held it in 11 quarters. The position peaked at $4.63K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 40 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.63K.
  • Newbridge Financial Services Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.63K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.